Prestige Consumer Healthcare (PBH) Accounts Payables (2011 - 2026)
Prestige Consumer Healthcare (PBH) posted quarterly Accounts Payables of $42.9 million for Q4 2025, up 120.17% year-over-year from $19.5 million in Q4 2024, and up 2.44% quarter-over-quarter from $41.9 million in Q3 2025.
Prestige Consumer Healthcare (PBH) Accounts Payables (2011 - 2026) Analysis & Trends
Prestige Consumer Healthcare's Accounts Payables history runs 15 years deep, the most recent figure standing at $42.9 million for Q4 2025.
- In Q4 2025, Accounts Payables rose 120.17% year-over-year to $42.9 million; the TTM figure through Dec 2025 stood at $42.9 million (up 120.17% YoY), while the FY2025 annual figure was $18.9 million, down 51.45% from the prior year.
- Accounts Payables for Q4 2025 stood at $42.9 million, up from $41.9 million in the prior quarter.
- The five-year high for Accounts Payables was $64.3 million in Q4 2022, with the low at $18.9 million in Q1 2025.
- The 5-year median for Accounts Payables is $41.0 million (2021), against an average of $42.4 million.
- Peak annual rise in Accounts Payables reached 120.17% in 2025, while the deepest fall reached 51.45% in 2025.
- Prestige Consumer Healthcare's Accounts Payables stood at $40.1 million in 2021, then jumped by 60.22% to $64.3 million in 2022, then tumbled by 38.78% to $39.3 million in 2023, then tumbled by 50.42% to $19.5 million in 2024, then surged by 120.17% to $42.9 million in 2025.
- Business Quant data shows PBH's Accounts Payables at $42.9 million in Q4 2025, $41.9 million in Q3 2025, and $22.2 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | -5.09 Bn |
| 2 | Teva Pharmaceutical Industries | 43.41 Bn | 39.75 Bn | 2.15 Bn | 2.72 Bn |
| 3 | Zoetis | 31.83 Bn | 30.15 Bn | 1.05 Bn | 452.00 Mn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.97 Bn | 5.10 Bn | 2.80 Bn |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | 497.80 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 1.73 Bn |
| 7 | Neurocrine Biosciences | 15.65 Bn | 15.26 Bn | 935.80 Mn | 808.30 Mn |
| 8 | Elanco Animal Health | 11.93 Bn | 11.40 Bn | 798.00 Mn | 427.00 Mn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | 356.00 Mn |
| 10 | Prestige Consumer Healthcare | 2.42 Bn | 2.36 Bn | - | 22.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 22.79 Mn |
| Dec 31, 2025 | 42.95 Mn |
| Sep 30, 2025 | 41.92 Mn |
| Jun 30, 2025 | 22.21 Mn |
| Mar 31, 2025 | 18.93 Mn |
| Dec 31, 2024 | 19.51 Mn |
| Sep 30, 2024 | 31.17 Mn |
| Jun 30, 2024 | 39.56 Mn |
| Mar 31, 2024 | 38.98 Mn |
| Dec 31, 2023 | 39.34 Mn |
| Sep 30, 2023 | 44.38 Mn |
| Jun 30, 2023 | 57.86 Mn |
| Mar 31, 2023 | 62.74 Mn |
| Dec 31, 2022 | 64.25 Mn |
| Sep 30, 2022 | 56.20 Mn |
| Jun 30, 2022 | 58.11 Mn |
| Mar 31, 2022 | 55.76 Mn |
| Dec 31, 2021 | 40.10 Mn |
| Sep 30, 2021 | 38.05 Mn |
| Jun 30, 2021 | 30.96 Mn |